{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreignpojfpjvaryu73phe3yi4vlc6gvjjghg66dhk3ozqq4oimos3h4",
    "uri": "at://did:plc:svcthvzunxmjidtlw23zva6n/app.bsky.feed.post/3mf2vufjzetu2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreiafleovwhv6kjawz7nf6r2kpkjwyrgdpfascdb2q7qeak3g5nwcmu"
    },
    "mimeType": "image/jpeg",
    "size": 16796
  },
  "path": "/2026/02/17/metabolons-metabolomics-platform-enables-largest-metabolomic-analysis-to-date-in-car-t-cell-therapy-revealing-new-insights-into-severe-neurotoxicity/",
  "publishedAt": "2026-02-17T14:00:00.000Z",
  "site": "https://laotiantimes.com",
  "tags": [
    "Cision PR Newswire"
  ],
  "textContent": "Metabolomics-Derived Pathway Scores Outperform Inflammatory Protein Markers—Delivering Risk Prediction Where Proteomics Falls Short MORRISVILLE, N.C., Feb. 17, 2026 /PRNewswire/ — Metabolon, Inc., the global leader in providing metabolomics solutions advancing a wide variety of life science research, diagnostic, therapeutic development, and precision medicine applications, today announced its industry-leading global metabolomics platform was used by researchers from […]",
  "title": "Metabolon’s Metabolomics Platform Enables Largest Metabolomic Analysis to Date in CAR T-Cell Therapy, Revealing New Insights into Severe Neurotoxicity"
}